Physician profile
William Lee
NPI 1982067484
$905.38
in general payments reported to CMS, 2019-2025
17 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $300 · 2023: $135 · 2024: $233 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $313.85 | 2022-2025 | |
| Bioventus LLC | $120.68 | 2022 | |
| Organogenesis INC. | $83.95 | 2024-2025 | Apligraf, Affinity |
| Merck Sharp & Dohme LLC | $67.24 | 2024 | Keytruda, Lynparza |
| Medtronic, INC. | $51.43 | 2024 | Symbotex |
| Hologic Sales and Service, LLC | $41.17 | 2023-2024 | Coolseal Generator, Trunode, Localizer |
| Kls-Martin L.P. | $28.28 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $26.25 | 2023 | Exparel |
| Genentech USA, INC. | $24.39 | 2023 | Tecentriq |
| Mimedx Group, INC. | $23.41 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $21.30 | 2025 | |
| Smith+Nephew, INC. | $21.23 | 2024 | Collagenase Santyl |
| Tela Bio, INC. | $19.31 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Heron Therapeutics, INC. | $17.80 | 2025 | Aponvie |
| Ethicon US, LLC | $17.47 | 2025 | Echelon Circular |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kedrion Biopharma, INC. | $13.84 | 2024 | Gammaked, Rhogam Ultra-Filtered Plus, Koate |
| Becton, Dickinson and Company | $13.78 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.